An unblinded randomized study of influenza A/H1N1 2009 resistance under standard and double dose oseltamivir treatment in participants with influenza

ational Centre for Immunisation Research and Surveillance (NCIRS)0 个研究点目标入组 125 人开始时间: 2010年1月5日最近更新: 2020年1月13日

适应症

试验速览

暂无简介。

•Participants must meet all of the following inclusion criteria to participate in this study:
•1. The age of the patient is at least 5 years.
•2. The patient has a positive rapid antigen test for influenza A and symptoms indicative of influenza that have lasted
•no more than 48 hours:
•- fever >= 37.8 celsius and
•- at least one respiratory symptom (cough, coryza, sore throat, rhinitis)

•If one or more of the following criteria are met, the participant will be ineligible to take part in this study:
•1. Clinical suspicion of infection with a respiratory virus other than influenza.
•2. Suspicion of invasive bacterial infection requiring immediate admission to hospital.
•3. Evidence of a poorly controlled underlying medical condition.
•4. Known immunosuppression (malignancy, transplant, drugs)
•5. Pregnant or lactating females
•6. Known allergy to oseltamivir.
•7. Participation in another clinical trial with an investigational drug.
•8. Participant with insufficient English language skills.
•9. A person about whom the investigator thinks that the person is unlikely to comply with the study requirements.

发起方

ational Centre for Immunisation Research and Surveillance (NCIRS)